About
Generics
Areas of Focus
Categories
Generic Drug
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
5
As Collaborator
6
Total Enrollment
693
By Phase
PHASE2/PHASE3: 2NA: 3PHASE2: 1PHASE4: 1PHASE1: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 8RECRUITING: 1UNKNOWN: 1AVAILABLE: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05004129Lead Sponsor
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
PHASE2/PHASE3Recruiting
76 participants
Started: Aug 23, 2021 · Completed: Dec 31, 2026
NCT03692312Lead Sponsor
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
PHASE2/PHASE3Completed
56 participants
Started: Mar 3, 2021 · Completed: Apr 4, 2023
NCT02958800Collaborator
Deprescribing Antipsychotics in Long-Term Care
NACompleted
6 participants
Started: Dec 31, 2016 · Completed: Aug 31, 2019
NCT02858908Lead Sponsor
Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
PHASE2Completed
16 participants
Started: Jul 20, 2016 · Completed: Jan 31, 2018
NCT02669641Collaborator
Complex Imaging Assessment of Steatosis
PHASE4Unknown
50 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2016
Locations (1)
Headquarters
Massy, France
Map
Loading map...